A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis

Post-COVID-19 pulmonary fibrosis (PCPF) is a long-term complication that appears in some COVID-19 survivors. However, there are currently limited options for treating PCPF patients. To address this problem, we investigated COVID-19 patients’ transcriptome at single-cell resolution and combined biolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Albert, Chen, Jhih-Yu, Hsu, Chia-Lang, Oyang, Yen-Jen, Huang, Hsuan-Cheng, Juan, Hsueh-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147547/
https://www.ncbi.nlm.nih.gov/pubmed/35631558
http://dx.doi.org/10.3390/pharmaceutics14050971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147547/
https://www.ncbi.nlm.nih.gov/pubmed/35631558
http://dx.doi.org/10.3390/pharmaceutics14050971

Ejemplares similares